Compass Pathways PlcEquity-NMS: CMPS
Equity-NMS: CMPS
$7.48
-0.16
(30 Aug)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$7.48
Open
$7.48
Today’s high
$7.83
Today’s low
$7.44
52W low
$5.01
52W high
$12.75
1Y
-17.35%
EPS (TTM)
-2.17
Shares O/S
68.39M
Market cap
511.54M
Insights
CMPS price is below its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Compass Pathways Plc

Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment.

COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need. .


FAQs

Can I buy Compass Pathways Plc shares in India?
How to buy Compass Pathways Plc shares in India?
What is the share price of Compass Pathways Plc?
What is the Market Capitalization of Compass Pathways Plc?
What is the PE ratio of Compass Pathways Plc?
Is Compass Pathways Plc a good stock to buy?
In which sector / industry does Compass Pathways Plc operate?